Beaumont HospitalProfessional Education

Radiation Therapy Physics Residency

The purpose of the residency is to provide the training necessary for the medical physics resident to become an independent academic clinical medical physicist in radiation therapy. This is achieved through a 3 year residency program, with two years focused on clinical training (preparing the resident for certification by the American Board of Radiology (ABR)), and a third research year, giving the resident the opportunity to establish a research path which can be expanded and further explored upon graduation from this program. 

The Beaumont Health radiation therapy physics residency is accredited by the Commission on Accreditation of Medical Physics Educational Programs (CAMPEP). The program follows all CAMPEP guidelines. The curriculum provides comprehensive, mentored, hands-on experience, and progressive responsibility providing the opportunity to work towards becoming fully independent by the time residents complete the program. Residents are eligible for Part II of the ABR certification exam upon completion of the second year of residency.

The program currently supports two residents. We do not anticipate any openings until early 2019.

Applicants should have a Masters or PhD in medical physics from a CAMPEP accredited program or a PhD from a closely related field and a certificate from CAMPEP. “A certificate program is a program of didactic coursework offered by a CAMPEP-accredited graduate or residency program, intended to enable individuals with a doctoral degree in physics or a related discipline to meet the didactic requirements needed to enter a CAMPEP-accredited residency program.” The Beaumont Medical Physics Residency is a clinical training program. The applicant is expected to have the necessary formal coursework in this field.

The Clinical Physics Division of Radiation Oncology at Beaumont is currently staffed with 20 physicists and 17 dosimetrists. We provide a full range of clinical services at three cancer centers at Royal Oak, Troy and Dearborn, including:

Proton therapy with pencil beam scanning (IBA ProteusOne superconducting synchrocyclotron)

  • IMRT
  • VMAT
  • SBRT
  • SRS
  • IGRT and Adaptive RT 
  • HDR/LDR brachytherapy, intravascular brachytherapy and electronic brachytherapy

The three centers maintain three large bore CT scanners (Philips), one large bore PET-CT (Philips), one large bore 3T MRI (Philips), one Gamma Knife unit (Elekta), ten high-energy linear accelerators (Elekta), as well as Pinnacle and RayStation planning systems and MOSAIQ OIS. Eight of the ten accelerators have onboard cone beam imaging capability; five of them have dynamic VMAT delivery function and six degree-of-freedom robotic table. Extra imaging and localization devices in external beam radiotherapy include 4D real-time ultrasound and Active Breathing Control device (Elekta). In addition, three Elekta

HDR units with online planning systems, ultrasound units, and C-arms are utilized in the brachytherapy program. It is anticipated that an Elekta MR linac will be installed in 2019.

Beaumont also has a medical residency program in radiation oncology and a dosimetry education program.


Statistics

There were approximately 30 applicants for the two current positions. Two new residents entered the program in February 2016. We do not anticipate any openings until early 2019.


Current Residents

Charbel_HabibCharbel Habib, Ph.D

Dr. Charbel Habib has a PhD in Biomedical Engineering and a master’s degree in Medical Physics from Wayne State University. He has more than a decade experience in magnetic resonance imaging and its application in neuroscience. During his residency’s research year, Dr. Habib is focused on using advanced MR techniques to study brain tumors (mainly Glioblastoma Multiforme (GBM)), and use multiparametric assessment to evaluate treatment response biomarkers and their correlation with patient outcome. In addition, Dr. Habib is working on 4D MR imaging and its application to imaging the thorax and abdomen, through a novel gating/sorting approach. These methods will play a key role in treatment planning (short term goal) and adaptive radiation therapy (long term goal).

David SolisDavid Solis, Ph.D

Dr. David Solis has a PhD and MS in Applied Physics from Rice University in Houston, TX. For his PhD, Dr. Solis studied in the field of nanophotonics, plasmonics and nanomaterials. His research focused on the development of new experimental methods for characterizing energy transfer along novel plasmonic waveguide systems using fluorescent confocal microscopy methods. In the research year of his residency, Dr. Solis has proposed a computational method for clinical stratification of lung cancer patients that would benefit most from proton treatment. This stratification of patients is to be done through training and implementation of a deep learning model, based on previously treated lung patients, that predicts and compares photon and proton dose distributions from a patient’s pre-treatment planning CT images and contours. The ability to accurately predict a patient’s expected dose distribution would provide physicians with a valuable clinical tool to determine the therapeutic capabilities for a given treatment modality and inform their decisions as to the best course of treatment for each patient.

Program Director

Patrick McDermott, Ph.D., FAAPM


Copyright © Beaumont Health. All Rights Reserved.